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1. Introduction
Existing synthetic vascular grafts have unacceptably high failure rates when replacing 
small diameter infrapopliteal vessels [1]. The lack of a confluent endothelial lining is 
repeatedly cited as the most common cause of conduit failure [2, 3]. In vitro graft 
endothelialisation is an emerging method, which has been shown in several long-term 
human clinical trials to significantly enhance the patency rates of small caliber 
synthetic grafts [4-7]. In this technique, autologous endothelial cells (ECs) are 
harvested from superficial veins or adipose tissue and seeded onto the graft lumen 
prior to implantation. Existing synthetic graft materials are however, poor substrates 
for cell culture and must be combined with coatings to promote cellular proliferation 
and adhesion [8, 9]. To date, a plethora of graft coatings have been investigated with 
no common consensus as to the most efficacious. The aim of this study is to compare 
the endothelialisation of the most commonly employed graft coating clinically; fibrin-
coated expanded polytetrafluoroethylene (ePTFE) with novel decellularised 
xenogenic extracellular matrix (ECM) scaffolds. ECM scaffolds support the growth of 
several cell types [10-12] and have already proven successful in reconstructing a wide 
range of specialised tissues [13-15]. The ECM scaffolds we are examining are derived 
from the porcine urinary bladder wall  - Urinary Bladder Matrix (UBM) and porcine 
jejunum - Small Intestine Submucosa (SIS). We hypothesise that an intact ECM 
scaffold would better approximate the natural vascular wall architecture than existing 
graft coatings and provide a superior substrate for in vitro endothelial seeding. We are 
specifically examining cellular viability, phenotype, attachment, growth and 
morphology. 
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2. Methods
 2.1 Preparation of scaffolds 
2.1.1 Urinary Bladder Matrix (UBM) Bioscaffolds  
A urinary bladder was obtained from market-weight pigs following euthanasia. 
Urothelial cells were removed by soaking the bladder in normal saline solution. 
The bladder was then incised via its apex and halved. The external layers of the 
bladder wall (tunica serosa, tunica muscularis externa, tunica submucosa, and the 
muscularis mucosa) were removed by mechanical delaminated. The remaining 
bilayered material including the basement membrane of the tunica mucosa layer 
(luminal surface) and the subadjacent tunica propria layer (abluminal surface) 
constitute UBM. Decellularisation was achieved by soakage in 0.1% (v/v) 
peracetic acid, 4% (v/v) ethanol and 95.9% (v/v) sterile water. The sheet was then 
soaked in distilled water with phosphate buffered saline to return the pH to 
neutrality.  Finally UBM was terminally disinfected by 10-kGy-gamma 
irradiation. 
2.1.2 Preparation of Small Intestine Submucosa (SIS) Bioscaffolds  
SIS was harvested from the porcine jejunum. Sections of rinsed jejunum were 
longitudinally spit to form an elongated sheet. The superficial mucosal and 
external muscular layers with surrounding serosa were extracted by physical 
delamination. The remaining layers; submucosa, muscularis mucosa and basilar 
layers of the mucosa, the most superficial of which is the stratum campactum (the 
luminal layer), constitute SIS. The side from which the muscular layers were 
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removed is the abluminal surface. This tissue was rinsed with phosphate buffered 
saline (pH = 7.0) and distilled water to lyse any remaining cells and remove
residual cellular debris. This was then sterilised with 0.1% peracetic acid and 20%
ethanol and finally 1.5 MRad gamma irradiation.
2.1.3 Fibrin Gel preparation  
The formation of fibrin gel has already been documented [16]. The production 
method is summarized here. Fibrinogen in tissue buffered saline (TBS) solution at 
a concentration of 10mg/ml was prepared. Thrombin solution was then made to 
get the final concentration of 40IU/ml of thrombin. Prior to use, 75ul of 50mM 
CaCl2 in tissue buffered saline was added to 75µl of 40IU/ml thrombin and 350µl 
of TBS. Then 500µl of fibrinogen solution was added and mixed with gentle 
shaking in 24 well plates. The gel was left for one hour to polymerise in an 
incubator at 37°C with 5% CO2 and 95% O2 environment. Fibrin glue was applied 
evenly to the graft surface using a sterile syringe. 
2.2 Sample preparation 
2.5cm diameter circular segments of each material was placed under sterile 
conditions between two stainless steel rings with inner diameters of 2.2cm such 
that 3.8 cm2 of the luminal graft surface was exposed. The luminal surfaces of 
UBM and SIS were used for seeding of cells.  
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2.3 Cell culturing technique  
Human umbilical vein endothelial (HUVEC) cell lines were purchased from 
Cascade Biologics/Invitrogen ®. HUVEC culture medium 200 was used and 
supplemented with low serum growth supplement (Cascade Biologics/Invitrogen). 
The media was replaced every 48 hours untill cells reached confluency. The cells 
were then split in a ratio 1:3 with 3mls buffered saline solution containing 0.25% 
trypsin and 0.09% ethylenediaminetetraacetic acid (EDTA).  
2.4 Seeding Protocols 
2.5cm diameter discs of each material were placed in six well culture dishes. The 
Sterile stainless-steel culture rings were placed over the scaffolds to prevent cell 
leakage. The cells were seeded at a density of 7×104 cells per cm2 in 3mls of 
culture media. The constructs were then left in an incubator for two hours to allow 
for cell adhesion. Thereafter the chambers were flooded with media and the 
constructs were returned to the incubator.  
2.5 Cellular Viability  
The cytotoxicity of the constructs to HUVECs was assessed by determining 
cellular viability using a live/dead viability assay (Invitrogen™). The 
methodology of this assay has been prescribed previously [17]. Images were 
captured using a Nikon Eclipse TE200 inverted microscope. 
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2.6 Immunofluorescence analysis of von Willebrand Factor (VWF) 
Endothelial cells seeded on each substrate were fixed with 3.7% para formaldehyde in 
phosphate buffered saline (PBS).  These were then rinsed with PBS and mixed for 20 
min with 0.27% NH4Cl/0.38% glycine in PBS and permeabilised with Triton X- 100 
(0.5%) in PBS. Von Willebrand Factor was confirmed via fluorescein-labeled 
Antibodies-conjugated mouse anti-human VWF antibodies (2 µgmL-1).  
 
2.7 Cellular Attachment  
Cellular adhesion was determined by examining the percentage of attached cells over 
time, seventh passage cells were used in each experiment. Uniform passages 
HUVECs (P7) of 7×104 cells per cm2 were seeded separately onto each material 
surface in a drop wise manner and incubated for a maximum of 120 minutes. At 30 
minute intervals, the surface of the constructs were rinsed with 5ml phosphate buffer 
solution (PBS) containing 0.4% v/v trypan blue to wash off any unattached cells. The 
detached cells were counted with a hemocytometer and expressed as a fraction of the 
original seeding density. 
 
2.8 Cellular Proliferation  
Cellular proliferation was assessed on days 1,3,5 and 7 using the tetrazolium 
compound 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
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sulfophenyl)-2H-tetrazolium (MTS) colorimetric assay. This assay has previously
been described [18].  
2.9 Scanning Electron Microscopy (SEM) 
Each construct with HUVECs was primarily fixed with 2.5% glutaraldehyde/ 
paraformaldehyde phosphate buffer solution. After primary fixation, the constructs 
were post-fixed in 2% Osmium Tetroxide then dehydrated through a graded series of 
acetones up to 100%. After critical point drying, the specimens were mounted onto 
aluminium stubs and then coated with gold. Samples were then analyzed using the 
Scanning Electron Microscope - JEOL 5510.  
 2.10 Statistical Analysis 
Statistical analyses were conducted using SPSS 22.0. Data was summarised using 
means and standard deviations. Statistical significance was determined as p ≤ 0.05. 
Each quantitative experiment was performed in triplicate.  For cell attachment, a 5x3 
factorial analysis of variance (ANOVA) was conducted to examine the effects of 
materials, time and the interaction between these two factors. For cell proliferation, a 
5x5 factorial analysis of variance was conducted to examine the effects of materials, 
test days and the interaction between these two factors. Where a significant 
interaction was found, this was explored using simple main effects analysis. Simple 
main effects of materials at each time (or test day) were conducted. The significant 
simple main effects of materials were further analysed by pairwise comparisons 
employing a Bonferroni adjustment for multiple comparisons. For cell attachment, for 
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each material the simple main effects of time were explored. Significant simple main 
effects of time were further analysed by pairwise comparisons using a Bonferroni 
adjustment for multiple comparisons. The underlying assumption of Normality was 
examined using Normal probability plots and the Shapiro-Wilk test. The homogeneity 
of variance test was examined by plotting the residuals of the model against the fitted 
values and the Levene’s test.  
3. Results
3.1 Cellular Viability  
Live/Dead assays showed that synthetic grafts, fibrin/ePTFE hybrid and the ECM 
scaffolds all support the viability of HUVEC cells in static culture, demonstrating that 
neither the scaffolds nor their coatings were cytotoxic to the HUVECs.  
3.2 Validation of endothelial cells 
In the immunofluorescence staining, intracellular VWF of HUVECs was confirmed 
on all materials. Figure one shows ECs cultured on Dacron expressing VWF, 
confirming that ECs were functioning appropriately. Cells cultured on the other 
scaffolds were also shown to be expressing VWF.  
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3.3 Cellular Attachment 
Data showing the proportion of cells attaching to each substrate over 120 minutes in 
culture is tabulated in figure two. For cell attachment, the 5x3 ANOVA indicated 
significant main effects of materials (p<0.001) and time (p<0.001), and a significant 
interaction between materials and time (p=0.016). The material by time interaction 
effect was analysed using simple main effects analysis. For each time point, 
significant differences between materials were found (p<0.001, for all). These 
significant simple main effects of materials were further analysed by pairwise 
comparisons using the Bonferroni adjustment for multiple comparisons. ECs seeded 
on both ECM scaffolds and fibrin-modified ePTFE achieved statistically higher 
attachment efficiency at each time point when compared to both synthetic graft 
materials (p ≤ 0.001). The adhesion rates between the ECM scaffolds and the fibrin-
coated ePTFE was statistically similar at each time point (p = 1.00). For each material, 
significant differences between time points were found (p<0.001, for all). These 
significant simple main effects of time were further analysed by pairwise comparisons 
using the Bonferroni adjustment for multiple comparisons. For all materials 
examined, cell attachment was significantly higher at 90 (p = 0.001) and 120 minutes 
(p = 0.001) compared to 60 minutes. There was no difference in attachment rates 
beyond 90 minutes (p > 0.05).   
262
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3.4 Cellular Proliferation 
Cell Proliferation for each material is illustrated in figure three. For cell proliferation, 
the 5x5 ANOVA indicated significant main effects of materials (p < 0.001) and test 
days (p < 0.001), and a significant interaction between materials and test days (p < 
0.001). The material by test day interaction effect was analysed using simple main 
effects analysis. For each test day, significant differences between materials were 
found (p < 0.001, for all). These significant simple main effects of materials were 
further analysed by pairwise comparisons using the Bonferroni adjustment for 
multiple comparisons. For days 3,5,7 and 9 cell proliferation was significantly higher 
on UBM, SIS and fibrin/ePTFE when compared to Dacron and ePTFE (p ≤ 0.001). 
From day three on, cells grew faster on the ECM scaffolds when compared to fibrin-
coated ePTFE (p ≤ 0.001).  ECs grown on ECM scaffolds achieved confluency the 
fastest (day seven) with no significant growth after this time (p = 1.000). There was 
no difference in cell proliferation at any time point between UBM and SIS (p = 
1.000). There was also no difference between ePTFE and Dacron at any time point (p 
= 1.000). Cells grown on fibrin/ePTFE hybrid or uncoated synthetic grafts failed to 
reach confluency by the end of the study (day nine).  
3.5 Cellular Morphology  
On uncoated ePTFE and Dacron cells appeared as small spheroid shapes with single 
point contact to the material (Fig. 4a). They were inhomogeneously distributed on the 
surface and aggregated in clusters. As illustrated, cell seeded onto ePTFE did not 
cover the prosthetic fibers uniformly and produced isolated clumps of cells with large 
sections of fibers exposed. Findings on Dacron were similar.  Fibrin/ePTFE hybrid 
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appeared to be almost completely covered by a homogeneous layer of cells. The cells
were well spread on the surface with a large mean cell–material contact area. Cells
grown on ECM scaffolds produced a similar pattern, a homogeneously distributed and 
well-spread monolayer, demonstrating a cobblestone morphology (Fig. 4b).
4. Discussion
The principle requirements for in vitro endothelialisation are rapid cell
proliferation and strong cellular attachment to minimise culture times and resist the 
haemodynamic forces upon implantation. We found cell attachment to Dacron was 
negligible, possibly due to the high porosity of the material resulting in leakage of the 
seeding solution (Fig. 2). Uncoated ePTFE displayed similarly poor attachment rates 
despite its smoother surface and smaller pore size. All biological scaffolds including 
fibrin/ePTFE hybrid supported stronger adhesion when compared to uncoated ePTFE 
and Dacron at each time point (p ≤ 0.001). The finding that fibrin enhances 
endothelial attachment are constant with the results of Zilla et al. [19]. Fibrin has 
excellent biocompatibility properties with a high affinity for biological surfaces [20]. 
It supports angiogenesis during wound healing and possesses several cellular 
attachment sites [21].  
Both ECM materials displayed equally high adhesion rates despite the different 
composition and topography of SIS and UBM. SIS possesses an interstitial like 
surface, while UBM contains a fully intact basement membrane [22]. While 
investigating graft endothelialisation, Baker et al. reported that endothelial cells 
attached equally well to the basement surface (collagen types IV and V) and 
interstitial surface (collagen types I and III) of human amnion [23]. The exact 
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attachment mechanisms of endothelial cells to ECM remains to be elucidated but is
likely to be multifactorial and complex. Adhesion proteins contained in ECM
scaffolds, such as fibronectin, collagen type I and laminin are widely recognised as
important attachment substrates for endothelial cells, encouraging growth and 
“sprout” formation [24, 25]. Growth factors identified in SIS and UBM enhance and 
may play a synergic role in promoting cellular attachment. Fibroblast growth factor 2 
(FGF-2), transforming growth factor beta (TGF-β) and vascular endothelial growth 
factor (VEGF) found in ECM are proven to encourage the adherence of endothelial
cells [26, 27].  These growth factors are bound to ECM proteoglycans and 
glycosaminoglycans, which protect them from degradation and enhance their
presentation to occupying cells [28]. Importantly these growth factors have been 
shown to survive the production and sterilisation steps in preparing ECM scaffolds for
medical use [29,30]. In the past, researchers have struggled to integrate purified forms
of growth factors into synthetic scaffolds [31]. Difficulties in the release and 
formulation of the correct combinations have lead to disappointing clinical results. In 
natural ECM biomaterials, these growth factors appear to be present in the correct
concentrations, isoforms and three-dimensional ultra structures [28].  As well as the
components of ECM scaffolds, the topography may also influence cellular adhesion. 
Several studies have reported changes in cellular behaviour depending on the
roughness of their substrates. This has lead to nanoscale engineering to influence
cellular orientation, growth, attachment and migration [32, 33]. Miller et al. reported 
the improved attachment and growth of ECs on poly (lactic-co-glycolic acid) (PLGA)
materials by mimicking the surface roughness of natural extra-cellular matrix [34]. 
The luminal surface of SIS and UBM comprise a dense compact basement membrane
like surface following the removal of the epithelial layer. The topography found in 
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ECM, may provide cells with a more natural nanosurface, resembling that found in 
vivo and positively influencing cell growth and attachment.  
 The morphological difference between cells grown on 
synthetic and biological grafts (SIS, UBM, fibrin/ePTFE) is striking. On ePTFE and 
Dacron (Fig. 5a), cells appear as small spheroid shapes with single point contact to 
the material. This morphology suggests that these cells have not yet acclimatized to 
the substrate and are poorly attached, essentially in a quiescent phase. They are 
inhomogeneously distributed on the surface and aggregate in clusters leaving large 
sections of graft fibers exposed. Cells grown on the biological substrates including the 
fibrin/ePTFE hybrid exhibited larger, flatter cell shapes with increased cytoplasmic 
extensions to the materials. These cells have greater numbers of attachment bonds to 
the substrate, thus increasing attachment strength. All cells examined on the 
biological substrates were beginning to form the typical cobblestone monolayer 
morphology as seen in vivo which is known to correlate with high levels of 
attachment and facilitate enhanced cellular proliferation [35]. Flattened phase 
endothelial cells are also in a shape most capable of allowing the streamlining of 
blood flow thus minimizing cell loss at implantation. 
 In vitro endothelialisation not only requires adequate 
cellular attachment, but also rapid proliferation. Slow proliferation increases 
incubation times leading to higher rates of contamination and production costs. This 
delays implantation and increases the initial cell harvest density required. Our results 
demonstrated that all materials studied, supported cellular proliferation to some extent 
(Fig. 3). Although cells grown on synthetic grafts remained viable and displayed 
consistent yet slow growth, they did not achieve confluency by the end of the study 
(day nine). The high porosity and poor cellular attachment may have initially delayed 
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cell-cell contact formation and therefore had a negative impact on cell growth. 
Furthermore, the fibrillar interstices of ePTFE and the Dacron fibers may have 
hindered cellular migration. Despite the excellent attachment rates achieved with 
fibrin-coated ePTFE, this success was not replicated when examining proliferation. 
The reason for this is not fully understood. Theoretically, fibrin is an excellent 
scaffold, supporting angiogenesis and tissue repair in vivo [36]. It also releases 
fibrinopeptides, which are known to be mitogenic for ECs [21]. Henrich et al. 
examined two types of fibrin glue and also discovered similarly high levels of 
attachment but weak proliferation [37]. The delayed proliferation of cells on 
fibrin/ePTFE could be explained by the dense matrix formed by the polymerisation of 
fibrinogen. Several studies have cited that this dense matrix could inhibit the 
migration and proliferation of cells [38,39]. Although fibrin did increase the 
proliferation rate when compared to uncoated ePTFE, this was insufficient to form a 
confluent endothelium within the time frame of this study. 
 Of all the vascular materials studied, cells proliferated 
fastest on ECM scaffolds with both reaching confluency at day seven. Each had 
statistically higher cell numbers from day three onward compared to all other 
scaffolds. It is generally accepted that cellular growth on biomaterials is highly reliant 
on the topography and composition of the substratum [40]. In vivo, ECM is crucial 
during angiogenesis, which involves endothelial growth and spreading [41-43].  ECM 
is rich in substances known to enhance angiogenesis such as the growth factor VEGF 
[27] and functional proteins such as laminin and fibronectin, which accelerate 
endothelial proliferation. Glycosaminoglycans present in ECM bind to growth factors 
and cytokines and encourage cellular growth. In vivo, the luminal surface of SIS and 
UBM support a continually dividing cellular layer; the small intestine enteriocytes in 
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SIS and transitional epithelium in UBM. These layers are repeatedly subjected to 
mechanical and infectious trauma, hence it is reasonable to assert, that ECM from 
such areas has evolved to maximise cellular growth and differentiation.  
 ECM materials are at the forefront of biomaterial 
research and have been successfully used in a diverse range of medical applications 
[13-15]. As our understanding of these materials increases, it is becoming more 
apparent that they possess many properties that would make them ideal for use in 
vascular tissue engineering. Extensive research has been carried out on ECM 
materials; particularly SIS and the results suggest that these scaffolds fulfill many of 
the design criteria proposed for a novel vascular graft. In terms of mechanical 
characteristics, SIS has an axial strength greater than that of the canine carotid artery 
[44]. It has enhanced compliance, which more closely approximates that of an artery 
when compared to ePTFE or Dacron grafts [44]. The compliance of ECM grafts could 
reduce intimal hyperplasia and this has been born out in several studies [45,46]. Burst 
pressure studies on SIS show it to be easily capable of resisting the continuous 
haemodynamic stresses in vivo [44] and animal studies of up to five years have not 
shown aneurysmal formation or graft failure [47].  
 
6. Conclusion 
The composition of intact ECM appears to be an ideal substrate for promoting rapid 
endothelialisation by combining firm cellular anchorage and rapid cell expansion. In a 
clinical setting where a finite number of cells are required to form a complete 
monolayer within a short time frame, firm cellular attachment combined with rapid 
endothelialisation will be important criteria in determining the success of this 
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emerging technology. Future studies would involve alternate cell lines including
endothelial progenitor cells or microvascular endothelial cells and examining their
behaviour when exposed to sheer stresses. In conclusion this work suggests that ECM
materials are promising scaffolds for small vessel tissue engineering.
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Fig. 1. Endothelial Cells expressing VWF on Dacron material. Cells grown on the other scaffolds 
were also shown to express VWF. Original magnification × 20 microscope objective. 
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Fig. 2. Comparison of the percentage of HUVEC attached on different substrates. The values are mean 
of three replicates in the case of each matrix (+/- 1 Standard Deviation) ★ denotes statistical
significance (p ≤ 0.001) of attachment rates on UBM, SIS and Fibrin/ePTFE grafts when compared to 
uncoated synthetic graft materials; ePTFE and Dacron. 
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Fig. 3 Cellular Proliferation Graph. The values are mean of three replicates in the case of each scaffold. 
★ denotes statistical significance  (p ≤ 0.001) of each result on ECM scaffolds relative to fibrin/ePTFE
hybrid graft materials. 
★
★
★
★
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Day  1 Day 3 Day 5 Day 7 Day 9
A
bs
o
rb
a
n
ce
 
(49
0n
m
)
Time (days)
Cellular Proliferation
Urinary Bladder Matrix
(UBM)
Small Intestine
Submucosa (SIS)
Fibrin/Polytetrafluoroeth
ylene (ePTFE)
Dacron
Polytetrafluoroethylene
(ePTFE)
278
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Fig. 4a. Endothelial Cells on ePTFE SEM × 1300 Magnification. Findings with Dacron were similar. 
Fig 4b. Endothelial Cells on SIS. SEM × 1300. Magnification. Findings on UBM and fibrin/ePTFE were 
similar. 
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